Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Drinks Industry News Once Upon A Coconut unveils Pineapple and Chocolate varieties US-based premium coconut water provider, Once Upon A Coconut, announces the expansion of its product line with the… byPallavi MadhirajuJune 28, 2023